DYRK1B haploinsufficiency in a Holstein cattle with epilepsy

被引:1
|
作者
Jacinto, Joana G. P. [1 ,2 ]
Bolcato, Marilena [1 ]
Haefliger, Irene M. [2 ]
Oevermann, Anna [3 ]
Gentile, Arcangelo [1 ]
Droegemueller, Cord [2 ]
机构
[1] Univ Bologna, Dept Vet Med Sci, Bologna, Italy
[2] Univ Bern, Inst Genet, Vetsuisse Fac, CH-3001 Bern, Switzerland
[3] Univ Bern, Vetsuisse Fac, Div Neurol Sci, DCR VPH, Bern, Switzerland
关键词
cattle; DNA double-strand; idiopathic epilepsy; precision medicine; seizure; TRANSCRIPTION; FAMILY; GENES;
D O I
10.1111/age.13348
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
In this study, epilepsy with focal seizures progressing to generalized seizures was diagnosed in a 6-month- old Holstein heifer. The seizures were characterized by a brief pre-ictal phase with depression and vocalization. During the ictal phase eyelid spasms, tongue contractions, nodding and abundant salivation were observed, rapidly followed by a convulsive phase with bilateral tonic, clonic or tonic-clonic activity and loss of consciousness. Finally, during the postictal phase the heifer was obtunded and disorientated, unable to perceive obstacles and hypermetric, and pressed its head against objects. In the inter- seizure phase, the heifer was clinically normal. Neuropathology revealed axonal degeneration in the brainstem and diffuse astrocytic hypertrophic gliosis. Whole genome sequencing of the affected heifer identified a private heterozygous splice-site variant in DYRK1B (NM_001081515.1: c.-101- 1G> A), most likely resulting in haploinsufficiency owing to loss-of- function. This represents a report of a DYRK1B-associated disease in cattle and adds DYRK1B to the candidate genes for epilepsy.
引用
收藏
页码:623 / 627
页数:5
相关论文
共 50 条
  • [41] Mirk/Dyrk1B modulates the development of chemoresistance in human ovarian cancer.
    Gao, Jingchun
    Li, Ji
    Gao, Heli
    Tian, Jianxin
    Lv, Yunyi
    Yang, Zhihai
    Zhang, Qiuping
    Kong, Fandou
    Pang, Jian
    Guan, Hongwei
    Shi, Hong
    CANCER RESEARCH, 2013, 73 (08)
  • [42] A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr286, not Thr288
    Ashford, Anne L.
    Oxley, David
    Kettle, Jason
    Hudson, Kevin
    Guichard, Sylvie
    Cook, Simon J.
    Lochhead, Pamela A.
    BIOCHEMICAL JOURNAL, 2014, 457 : 43 - 56
  • [43] Mirk/Dyrk1B controls ventral spinal cord development via Shh pathway
    Kokkorakis, N.
    Douka, K.
    Nalmpanti, A.
    Politis, P. K.
    Zagoraiou, L.
    Matsas, R.
    Gaitanou, M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [44] Analysis of DYRK1B, PPARG, and CEBPB Expression Patterns in Adipose-Derived Stem Cells from Patients Carrying DYRK1B R102C and Healthy Individuals During Adipogenesis
    Armanmehr, Azam
    Jafari Khamirani, Hossein
    Zoghi, Sina
    Dianatpour, Mehdi
    METABOLIC SYNDROME AND RELATED DISORDERS, 2022, 20 (10) : 576 - 583
  • [45] Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors
    Anderson, Kevin
    Chen, Yi
    Chen, Zhi
    Dominique, Romyr
    Glenn, Kelli
    He, Yang
    Janson, Cheryl
    Luk, Kin-Chun
    Lukacs, Christine
    Polonskaia, Ann
    Qiao, Qi
    Railkar, Aruna
    Rossman, Pamela
    Sun, Hongmao
    Xiang, Qing
    Vilenchik, Masha
    Wovkulich, Peter
    Zhang, Xiaolei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (24) : 6610 - 6615
  • [46] Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288
    Zou, YL
    Ewton, DZ
    Deng, XB
    Mercer, SE
    Friedman, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) : 27790 - 27798
  • [47] The role of DYRK1B in cancer cells in response to DNA damage and changes in phenotypic plasticity
    Wilms, G.
    Schwandt, K.
    Ahiburg, J.
    Babendreyer, A.
    Kraft, F.
    Becker, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 : S23 - S23
  • [48] The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk/Dyrk1B in ovarian cancer
    Gao, Jingchun
    Yang, Xiangjun
    Yin, Ping
    Hu, Wenfeng
    Liao, Hongfeng
    Miao, Zhihui
    Pan, Chao
    Li, Na
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (04) : 1203 - 1209
  • [49] DYRK1B inhibitors prevent pharmacologic quiescence and sensitize lung cancers to EGFR inhibitors
    Vilenchik, Maria
    Kuznetsova, Alexandra
    Frid, Michael
    Gankin, Yuriy
    Duey, Marc
    Rosen, Neal
    CANCER RESEARCH, 2017, 77
  • [50] Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition
    Hu, Jing
    Deng, Holly
    Friedman, Eileen A.
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (10) : 2258 - 2269